Stock Ticker

  • Loading stock data...

ChromaDex Trades Higher as RedChip Announces Research Update (CDXC)

Penny stocks like ChromaDex (OTC: CDXC) are traded in high volumes and the smallest amount of news can change the value of the stock for the good as well as the bad. RedChip Companies has just released its research update for ChromaDex after the latter presented at the Small-Cap Virtual Conference hosted by RedChip Companies. The research report was followed with the news release that the videos of the companies presenting at the conference will now be available at the official RedChip website and will be open to online viewers. ChromaDex shares have risen by a substantial 4.8%, or $0.04 to close at $0.88 per share.

Association with RedChip

RedChip Companies is an internationally acclaimed small-cap research and investor relations firm. Its virtual investor conferences are known for the insight that they offer to investors. Held throughout the year, these conferences include at least a dozen of the most active publicly traded companies. RedChip does not isolate companies from any particular industry. Therefore, investors receive an opportunity to hear presentations from companies that come from a variety of industries such as alternative energy, oil & gas, manufacturing, consumer goods, raw materials, construction, biotechnology, industrial mining and more.

ChromaDex had the privilege of being one of the 14 emerging growth companies from all the sectors asked to present at the conference. Other companies that were also a part of the conference and are traded in the OTC markets were Catasys (OTC: CATS) and Liquidmetal Technologies (OTC: LQMT).

Catasys is a specialized health management service provider. Its share prices have remained steady at $0.15 from the last trading session to the end of this one. Liquidmetal Technologies is into the research and commercialization of amorphous metals. Its share prices have fallen, albeit by a small margin. The closing share price in today’s trading session is $0.24, which is down $0.005 from the previous session.

Research Report and Analysis for ChromaDex

Established in 1999, ChromaDex is a natural products company that specializes in providing proprietary solutions and ingredients that have a science base. ChromaDex products are used in the pharmaceutical industry, supplements and nutrition markets, food and dietary industry, as well as the cosmetics development market. ChromaDex does not seem to be content with putting all its eggs in a single basket. It seems to have found the inclination and understanding that being diversified can bring stability.

Forbes 400 billionaire, Philip Frost, who is also the Vice Chairman of Teva Pharmaceuticals, happens to be one of the key investors in ChromaDex. The company has also come to partnership agreements with well-recognized international brands such as Chandler Chicco and Alcone in order to expand its branded retail line access.

Cooperation

RedChip is by no means a small company. It has international reach and any publicity by the company is good visibility for a high volume penny stock like ChromaDex. RedChip is now hosting the research report and analysis of ChromaDex using data over the last few years on its official website. This has translated into a substantial bump in share prices for ChromaDex.

Published by Benjamin Roussey

Benjamin Roussey is from Sacramento, California. He has two master’s degrees and served four years in the U.S. Navy. His bachelor’s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master’s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http://www.facebook.com/ben.rouss



  • Recent Stories

    SignUp Now For Our Featured Newsletter

    Sign Up To Get Our Latest Stocks Alerts